Search results: Sage Journals

Restricted accessReview articleFirst published August, 2021

Potential and unsolved problems of anti-PD-1/PD-L1 therapy combined with radiotherapy

Yiyi Cao, Wenbo Li, ZhengJie Wang [...]

Tumori Journal

Open accessResearch articleFirst published 2020

Optimizing Sequence of PD-L1 Immune-Checkpoint Inhibitors and Radiation Therapy in Bladder Cancer

Côme Tholomier, Gautier Marcq, Surashri Shinde-Jadhav [...]

Bladder Cancer

Restricted accessResearch articleFirst published November, 2021

Targeted PD-L1 PLGA/liposomes-mediated luteolin therapy for effective liver cancer cell treatment

Xinqiao Cao, Bing Wang

Journal of Biomaterials Applications

Open accessBrief reportFirst published December 13, 2021

CD274 ( PD-L1 ) Copy Number Changes (Gain) & Response to Immune Checkpoint Blockade Therapy in Carcinomas of the Urinary Tract

Sounak Gupta, Chad M. Vanderbilt, Yanming Zhang [...]

Bladder Cancer

Open accessResearch articleFirst published 2019

Prognostic value of PD-L1 expression for surgically treated localized renal cell carcinoma: implications for risk stratification and adjuvant therapies

Juan Chipollini, Walter Henriques da Costa, Isabela Werneck da Cunha [...]

Therapeutic Advances in Urology

Open accessCase reportFirst published January, 2025

SMARCB1/INI-1-Deficient sinonasal carcinoma demonstrates a poor prognosis but favorable clinical outcomes after PD-1/PD-L1 inhibitor therapy: A case series

Shuhan Zhao, Hao Du, Zhanjie Zhang [...]

Science Progress

Open accessResearch articleFirst published March 19, 2024

Missing prognostic value of soluble PD-1,PD-L1 and PD-L2 in lung cancer patients undergoing chemotherapy – A CEPAC-TDM biomarker substudy

Kimberly Geiger, Markus Joerger, Max Roessler [...]

Tumor Biology

Open accessReview articleFirst published 2019

PD-L1/PD-1 Biomarker for Metastatic Urothelial Cancer that Progress Post-platinum Therapy: A Systematic Review and Meta-analysis

Wei Phin Tan, Wei Shen Tan, Brant A. Inman

Bladder Cancer

Restricted accessReview articleFirst published November, 2017

Targeting the Pd-1 Pathway in Renal Cell Carcinoma: A Review

Lisa Derosa, Laurence Albiges, Bernard Escudier

Journal of Onco-Nephrology

Open accessResearch articleFirst published 2024

Pretreatment pulmonary tumor necrosis is a promising prognostic imaging biomarker for first-line anti-PD-1/PD-L1 therapy in advanced lung squamous cell carcinoma: a multi-institutional,propensity score-matching cohort analysis

Qiaofeng Zhong, Longfeng Zhang, Lin Wu [...]

Therapeutic Advances in Medical Oncology

Restricted accessReview articleFirst published August, 2021

Potential and unsolved problems of anti-PD-1/PD-L1 therapy combined with radiotherapy

Yiyi Cao, Wenbo Li, ZhengJie Wang [...]

Tumori Journal

Open accessResearch articleFirst published 2020

Optimizing Sequence of PD-L1 Immune-Checkpoint Inhibitors and Radiation Therapy in Bladder Cancer

Côme Tholomier, Gautier Marcq, Surashri Shinde-Jadhav [...]

Bladder Cancer

Restricted accessResearch articleFirst published November, 2021

Targeted PD-L1 PLGA/liposomes-mediated luteolin therapy for effective liver cancer cell treatment

Xinqiao Cao, Bing Wang

Journal of Biomaterials Applications

Open accessBrief reportFirst published December 13, 2021

CD274 ( PD-L1 ) Copy Number Changes (Gain) & Response to Immune Checkpoint Blockade Therapy in Carcinomas of the Urinary Tract

Sounak Gupta, Chad M. Vanderbilt, Yanming Zhang [...]

Bladder Cancer

Open accessResearch articleFirst published 2019

Prognostic value of PD-L1 expression for surgically treated localized renal cell carcinoma: implications for risk stratification and adjuvant therapies

Juan Chipollini, Walter Henriques da Costa, Isabela Werneck da Cunha [...]

Therapeutic Advances in Urology

Open accessCase reportFirst published January, 2025

SMARCB1/INI-1-Deficient sinonasal carcinoma demonstrates a poor prognosis but favorable clinical outcomes after PD-1/PD-L1 inhibitor therapy: A case series

Shuhan Zhao, Hao Du, Zhanjie Zhang [...]

Science Progress

Open accessResearch articleFirst published March 19, 2024

Missing prognostic value of soluble PD-1,PD-L1 and PD-L2 in lung cancer patients undergoing chemotherapy – A CEPAC-TDM biomarker substudy

Kimberly Geiger, Markus Joerger, Max Roessler [...]

Tumor Biology

Open accessReview articleFirst published 2019

PD-L1/PD-1 Biomarker for Metastatic Urothelial Cancer that Progress Post-platinum Therapy: A Systematic Review and Meta-analysis

Wei Phin Tan, Wei Shen Tan, Brant A. Inman

Bladder Cancer

Restricted accessReview articleFirst published November, 2017

Targeting the Pd-1 Pathway in Renal Cell Carcinoma: A Review

Lisa Derosa, Laurence Albiges, Bernard Escudier

Journal of Onco-Nephrology

Open accessResearch articleFirst published 2024

Pretreatment pulmonary tumor necrosis is a promising prognostic imaging biomarker for first-line anti-PD-1/PD-L1 therapy in advanced lung squamous cell carcinoma: a multi-institutional,propensity score-matching cohort analysis

Qiaofeng Zhong, Longfeng Zhang, Lin Wu [...]

Therapeutic Advances in Medical Oncology